$200.00
Tirzepatide 5 mL Vial
The Science, Simplified: Tirzepatide is a synthetic dual agonist peptide studied as a GIP and GLP-1 receptor pathway research tool in laboratory and preclinical models.
Product Specifications – Tirzepatide 5 mL Vial (50 mg)
Key Research Focus: Used for dual incretin-receptor assays that examine concurrent GIP and GLP-1 signaling at a straightforward 10 mg/mL liquid concentration.
Physical Form & Solubility:
Stability & Handling Notes:
Tirzepatide 50 mg / 5 mL (10 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.
How Labs Use This Format: Labs pipette from this sealed 5 mL ready-to-use liquid vial at 10 mg/mL for dual GIP/GLP-1 receptor pathway work. Tirzepatide pen formats may be available in the metabolic pens category.
Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records for this 50 mg Tirzepatide vial. Cold-pack shipping on qualifying orders.
For laboratory research use only (RUO). Not for human use, veterinary use, household use, or consumption. Not a drug, food, supplement, or cosmetic. Not intended to diagnose, treat, cure, or prevent any disease. Buyer represents they are a qualified researcher purchasing for lawful research purposes only.
Image coming soon. Dual GIP/GLP-1 receptor agonist research vial in a 50 mg / 5 mL liquid fill. Distinct from the Retatrutide multi-receptor line; COA with every lot.
Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.
Read the Tirzepatide research overview
Join the list for new compounds, research notes, and subscriber-only offers.
For more information on how we process your data for marketing communication. Check our Privacy policy.